Indian pharma
India Can Unlock Rs 12 Lakh Crore R&D Opportunity Through Cost Advantage:Piyush Goyal
News
September 9, 2026
India Can Unlock Rs 12 Lakh Crore R&D Opportunity Through Cost Advantage:Piyush Goyal
India can unlock a Rs 12 lakh crore opportunity in research and development (R&D) by leveraging its cost advantage and…
GST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026
Business
December 26, 2025
GST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian…